Evidence map›Paper›PMID 35585975›Full record

ReviewFrontiers in immunology2022

Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy.

Peng Ding, Zhiqiang Ma, Dong Liu, Minghong Pan, Huizi Li, Yingtong Feng, Yimeng Zhang, Changjian Shao, Menglong Jiang, Di Lu and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Peng DingDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Zhiqiang MaDepartment of Medical Oncology, Senior Department of Oncology, Chinese People''s Liberation Army of China (PLA) General Hospital, The Fifth Medical Center, Beijing, China.
Dong LiuState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Minghong PanDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Huizi LiDepartment of Outpatient, PLA Rocket Force Characteristic Medical Center, Beijing, China.
Yingtong FengDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Yimeng ZhangDepartment of Ophthalmology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Changjian ShaoDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Menglong JiangDepartment of Thoracic Surgery, 1st Affiliated Hospital of Anhui Medical University, Hefei, China.
Di LuDepartment of Medical Oncology, Senior Department of Oncology, Chinese People''s Liberation Army of China (PLA) General Hospital, The Fifth Medical Center, Beijing, China.
Jing HanDepartment of Ophthalmology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Jinliang WangDepartment of Medical Oncology, Senior Department of Oncology, Chinese People''s Liberation Army of China (PLA) General Hospital, The Fifth Medical Center, Beijing, China.
Xiaolong YanDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Tang Du Hospital · CNChinese People's Liberation Army · CNAir Force General Hospital PLA · CNAnhui Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As major post-translational modifications (PTMs), acetylation and deacetylation are significant factors in signal transmission and cellular metabolism, and are modulated by a dynamic process

Indexed as

LysineNeoplasmsAcetylationHumansImmunotherapyProtein Processing, Post-TranslationalLysineacetylationCancerdeacetylationHATHDACimmunotherapy

Identifiers

PMID35585975
PMCPMC9108232
OpenAlexW4225291721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.